Essential Thrombocythemia in Does and Cats - Part II

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 21, Issue 3, 1999, Pages 218-229

  Chisholm Chait, Alexandra ^a,b  

^a AUBURN UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; FELIS CATUS;

EID: 0346449657     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Simpson JW, Else RW, Honeyman P: Successful treatment of suspected essential thrombocythaemia in the dog. J Small Anim Pract 31(7):345-348, 1990.
2. Hopper PE, Mandell CP, Turrel JM, et al: Probable essential thrombocythemia in a dog. J Vet Intern Med 3(2):79-85, 1989.
3. Hammer AS, Couto CG, Getzy D, Bailey MQ: Essential thrombocythemia in a cat. J Vet Intern Med 4(2):87-91, 1990.
4. Hehlmann R, Jahn M, Bawmann B, et al: Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 61:2487-2496, 1988.
5. Kutti J, Wadenvik H: Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis. Leuk Lymphoma 22(Suppl 1):41-45, 1996.
6. Michiels JJ: Criteria for the clinicopathological diagnosis of primary thrombocythaemia. First Meeting of the European Haemotology Association. European Working Group on the Myeloproliferative Syndromes, 1994.
7. Tablin F, Jain NC, Mandell CP, et al: Ultrastructural analysis of platelets and megakaryocytes from a dog with probable essential thrombocythemia. Vet Pathol 26(4):289-293, 1989.
8. Thiele J, Schneider G, Hoeppner B, et al: Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis - Features of significance for the diagnosis of (essential) thrombocythaemia. Virchos Arch [A] 413:407-417, 1988.
9. Zahavi J, Zahavi M, Firsteter E, et al: An abnormal pattern of multiple platelet function abnormalities and increased thromboxane generation in patients with primary thrombocytosis and thrombotic complications. Eur J Haematol 13: 9-15, 1991.
10. Dudley JM, Messinezi M, Eridani S, et al: Primary thrombocythaemia: Diagnostic criteria and a simple scoring system for positive diagnosis. Br J Haemotol 71:331-335, 1989.
11. Young KM, MacEwen EG: Canine myeloproliferative disorders, in Withrow SJ, MacEwen EG (eds): Small Animal Clinical Oncology. Philadelphia, WB Saunders Co, 1996, pp 495-505.
12. Peterson ME, Randolph JK: Diagnosis of canine primary polycythemia and management with hydroxyurea. JAVMA 180:415-418, 1982.
13. Carneskog J, Wadenvik H, Fjalling M, Kutti J: Assessment of spleen size using gamma camera scintigraphy in newly diagnosed patients with essential thrombocythaemia and polycythaemia vera. Eur J Haematol 56(3):158-162, 1996.
14. Donehower RC: Hydroxyurea, in Chaner B (ed): Pharmacological Principles of Cancer Treatment. Philadelphia, WB Saunders Co, 1982, p 269.
15. Anker-Lugtenberg PJ: Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyurea. Am J Hematol 33:152, 1990.
16. Weinfield A, Swolin B, Westin J: Acute leukemia after hydroxyurea therapy in polycythemia vera and allied disorders: Prospective studies of efficacy and leukaemogenicity with therapeutic implications. Eur J Haematol 52:134-139, 1994.
17. 32P) treatment of bone marrow disorders in dogs: 11 cases (1970-1987). JAVMA 194(1):98-102, 1989.
18. Frazier DL, Hahn KA: Commonly used drugs, in Hahn KA, Richardson RC (eds): Cancer Chemotherapy, A Veterinary Handbook. Baltimore, Williams & Wilkins, pp 106-107, 1995.
19. MacEwen EG: Biological response modifiers: The future of cancer therapy? Vet Clin North Am 20(4):1055-1073, 1990.
20. Lengfelder E, Griesshammer M, Hehlmann R: Interferon-alpha in the treatment of essential thrombocythemia. Leuk Lymphoma (22 Suppl 1):135-142, 1996.
21. Wadenvik H, Kutti J, Ridell B, et al: The effect of alpha-interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia. Blood 77:2103-2108, 1991.
22. Ganser A, Carlo-Stella C, Greher J, et al: Effect of recombinant interferons alpha and gamma on human bone marrow derived megakaryocyte progenitor cells. Blood 70:1173-1179, 1987.
23. Cummins JM, Tompkins MF, Olsen RG, et al: Oral use of human interferon alpha in cats. J Biol Resp Mod 7:513, 1988.
24. Silverstein MN, Petitt RM, Solberg LA Jr, et al: Anagrelide: A new drug for treating thrombocytosis. N Engl J Med 318 (20):1292-1294, 1988.
25. Balduini CL, Bertolino G, Noris P, Ascari E: Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. Haematologica 77(1):40-43, 1992.
26. Petitt RM, Silverstein MN, Petrone ME: Anagrelide for control of thrombocythemia in polycythemia and other myelo-proliferative disorders. Semin Hematol 34(1):51-54, 1997.
27. Frenkel EP: The clinical spectrum of thrombocytosis and thrombocythemia. Am J Med Sci 301(1):69-80, 1991.
28. Schafer A: Bleeding and thromboses in the myeloproliferative disorders. Blood 64:1-12, 1984.
29. Mitus AJ, Barbui T, Shulmar LN, et al: Hemostatic complications in young patients with essential thrombocythemia. Am J Med 88:371-375, 1990.
30. Degen MA, Feldman BF, Turrel JM, et al: Thrombocytosis associated with a myeloproliferative disorder in a dog. JAVMA 194(10):1457-1459, 1989.
31. Feldman BF, Thomason KJ, Jain NC: Quantitative platelet disorders. Vet Clin North Am Small Anim Pract 18(1):35-49, 1988.
32. Benzinger TA, Logue GL, Rundles RW: Hemorrhagic thrombocythemia; control of postsplenectomy thrombocytosis with melphalan. Blood 36:61-69, 1970.
33. Warren MK, Conrot LB, Rose JS: The role of C6 and interleukin 1 in megakaryocyte development. Exp Hematol 17: 1095-1099, 1989.
34. Hollen CW, Henthorn J, Koziol JA, Burstein SA: Serum interleukin-6 levels in patients with thrombocytosis. Leuk Lymphoma 8(3):235-241, 1992.
35. Tefferi A, Ho TC, Ahmann GJ, et al: Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis. Am J Med 97(4):374-378, 1994.
36. Majer RV, Dawe A, Weir P, et al: Which tests are most useful in distinguishing between reactive thrombocytosis and the thrombocytosis of myeloproliferative disease? Clin Lab Haematol 13:9-15, 1991.
37. Messinezy M, Westwood N, Sawyer B, et al: Primary thrombocythaemia: A composite approach to diagnosis. Clin Lab Haematol 16(2):139-148, 1994.
38. Cashell AW, Buss DH: The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states. Ann Hematol 64(6):273-276, 1992.
39. Jacobsson S, Carneskog J, Ridell B, et al: Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis. Eur J Haematol 56(5):287-292, 1996.
40. Kanz L, Hollen C, Friese P, et al: Analysis of megakaryocyte ploidy in patients with thrombocytosis. Int J Cell Cloning 8:299-306, 1990.
41. Conklin RJ, Tomer A, Friese P, et al: Flow cytometric analysis of megakaryocytes (MKs) from patients with platelet disorders. Prog Clin Biol Res 356:303-317, 1990.
42. Florensa L, Besses C, Woessner F, et al: Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythemia. Leukemia 9:271-273, 1995.
43. Rolovic Z, Basara N, Gotic M, et al: The determination of spontaneous megakaryocyte colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis. Br J Haematol 90(2): 326-331, 1995.
44. Juvonen E, Ikkala E, Oksanen K, Ruutu T: Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: Diagnostic value and correlation to complications. Br J Haematol 83(2):192-197, 1993.
45. Sawyer BM, Westwood NB, Pearson TC: Circulating megakaryocytic progenitor cells in patients with primary thrombocythaemia and reactive thrombocytosis: Results using a serum-deprived culture assay and a positive detection technique. Eur J Haematol 53(2):108-113, 1994.